GlassScriptPhysician profile
Neil A Mushlin
NPI 1639387418
$360,126.76
in general payments reported to CMS, 2019-2025
52 companies · $34K in 2025
The $34K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $28K · 2021: $108K · 2022: $72K · 2023: $29K · 2024: $39K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Food and Beverage: $27K · Honoraria: $6,500 · Consulting Fee: $6,318 · Education: $850 · Travel and Lodging: $22.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,442.75 |
| Food and Beverage | $27,166.15 |
| Honoraria | $6,500.00 |
| Consulting Fee | $6,317.50 |
| Education | $849.58 |
| Travel and Lodging | $22.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $69,344.97 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $47,997.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $45,366.61 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Baxter Healthcare | $43,556.27 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Volara System, Hillrom - Vest System Model 205 Acute Care |
| Mallinckrodt Hospital Products INC. | $33,045.91 | 2020-2025 | Acthar |
| Genentech USA, INC. | $27,249.47 | 2019-2025 | Xolair |
| Harmony Biosciences LLC | $25,508.72 | 2020-2025 | Wakix |
| Mallinckrodt Enterprises LLC | $18,085.23 | 2019 | |
| Grifols USA, LLC | $11,948.29 | 2019-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $7,180.25 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $5,994.83 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Philips North America LLC | $2,300.67 | 2019-2024 | (Ak6) Vest Therapy |
| Axsome Therapeutics, INC. | $2,290.40 | 2022-2025 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,071.16 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $1,930.38 | 2021-2025 | Tezspire, Tavneos |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,797.33 | 2024-2025 | Flexitouch Plus, Entre Plus |
| Mylan Specialty L.P. | $1,593.01 | 2019-2024 | Yupelri |
| Optinose US, INC. | $1,519.24 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $1,142.68 | 2019-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $1,041.06 | 2023-2025 | Lumryz |
| Inspire Medical Systems, INC. | $916.46 | 2021-2025 | Inspire |
| Grifols Shared Services North America, INC. | $820.00 | 2023 | Prolastin-C Liquid |
| Insmed, INC. | $742.30 | 2020-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $709.68 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $583.92 | 2019-2025 | Dupixent |
| Sunovion Pharmaceuticals INC. | $548.74 | 2019 | |
| Zoll Respicardia, INC. | $548.23 | 2022-2023 | Remede System |
| Paratek Pharmaceuticals, INC. | $548.04 | 2023-2025 | Nuzyra, Xhance |
| Ani Pharmaceuticals, INC. | $475.69 | 2022-2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $461.15 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $424.95 | 2019-2022 | |
| United Therapeutics Corporation | $347.51 | 2021-2025 | Tyvaso, Tyvaso |
| Teva Pharmaceuticals USA, INC. | $345.95 | 2019-2022 | |
| Viatris Specialty LLC | $267.86 | 2025 | Yupelri |
| Electromed, INC. | $253.86 | 2023-2025 | Smartvest |
| Kaleo, INC. | $175.08 | 2019-2022 | |
| Inogen, INC. | $165.66 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Resmed Corp | $124.54 | 2019-2025 | |
| Pulmonx Corporation | $113.74 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Pfizer INC. | $103.70 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Lilly USA, LLC | $65.96 | 2025 | Zepbound |
| Genentech, INC. | $54.06 | 2019 | |
| Azurity Pharmaceuticals, INC. | $46.05 | 2023-2025 | Horizant, Horizant |
| Circassia INC. | $44.99 | 2019 | |
| 3b Medical, INC. | $43.99 | 2024-2025 | Luna |
| Phadia US INC. | $29.20 | 2021 | |
| Csl Behring | $27.30 | 2020 | |
| Vifor Pharma, INC. | $23.93 | 2024 | Zemaira |
| Linus Health, INC. | $19.52 | 2024 | Core Cognitive Evaluation |
| Nabriva Therapeutics, Plc | $16.82 | 2022 | |
| Itamar Medical INC | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Mushlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.